L-069-2021

Agreement ID
L-069-2021
Lead IC
NCI
Exclusivity
Exclusive
External Party
Cytovia Therapeutics
Fiscal Year
2021
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-4436     High-Affinity Mouse Monoclonal Antibodies to GPC-3 for Liver Cancer Research
TAB-4113     New Chimeric Antigen Receptor (CAR) Format for Developing Improved Adoptive Cell Therapies